Maristela S Schaufelberger, Fabio L S Duran, Julia M Lappin, Marcia Scazufca, Edson Amaro, Claudia C Leite, Claudio C de Castro, Robin M Murray, Philip K McGuire, Paulo R Menezes, Geraldo F Busatto
{"title":"Grey matter abnormalities in Brazilians with first-episode psychosis.","authors":"Maristela S Schaufelberger, Fabio L S Duran, Julia M Lappin, Marcia Scazufca, Edson Amaro, Claudia C Leite, Claudio C de Castro, Robin M Murray, Philip K McGuire, Paulo R Menezes, Geraldo F Busatto","doi":"10.1192/bjp.191.51.s117","DOIUrl":"https://doi.org/10.1192/bjp.191.51.s117","url":null,"abstract":"<p><strong>Background: </strong>In low- and middle-income countries people with schizophrenia are reported to experience better outcomes than those in high-income countries.</p><p><strong>Aims: </strong>To examine structural brain differences in people with first-episode psychosis and controls in Brazil.</p><p><strong>Method: </strong>Magnetic resonance imaging using voxel-based morphometry was performed on 122 people with first-episode psychosis and 94 controls.</p><p><strong>Results: </strong>There were significant decreases in grey matter in the left superior temporal and inferior prefrontal cortices, insula bilaterally and the right hippocampal region in first-episode psychosis (P<0.05, corrected for multiple comparisons). The subgroup of people with schizophrenia (n=62) exhibited a similar pattern of decrease in grey matter relative to controls.</p><p><strong>Conclusions: </strong>Structural abnormalities reported in psychosis in high-income countries are also present in first-episode psychosis in Brazil.</p>","PeriodicalId":77411,"journal":{"name":"The British journal of psychiatry. Supplement","volume":"51 ","pages":"s117-22"},"PeriodicalIF":0.0,"publicationDate":"2007-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1192/bjp.191.51.s117","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41052673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dagmar Versmissen, Inez Myin-Germeys, Ilse Janssen, Nicolas Franck, Nicolas Georgieff, Joost a Campo, Ron Mengelers, Jim van Os, Lydia Krabbendam
{"title":"Impairment of self-monitoring: part of the endophenotypic risk for psychosis.","authors":"Dagmar Versmissen, Inez Myin-Germeys, Ilse Janssen, Nicolas Franck, Nicolas Georgieff, Joost a Campo, Ron Mengelers, Jim van Os, Lydia Krabbendam","doi":"10.1192/bjp.191.51.s58","DOIUrl":"https://doi.org/10.1192/bjp.191.51.s58","url":null,"abstract":"<p><strong>Background: </strong>A disorder of self-monitoring may underlie the positive symptoms of psychosis. The cognitive mechanisms associated with these symptoms may also be detectable in individuals at risk of psychosis.</p><p><strong>Aims: </strong>To investigate (a) whether patients with psychosis show impaired self-monitoring, (b) to what degree this is associated with positive symptoms, and (c) whether this is associated with liability to psychotic symptoms.</p><p><strong>Method: </strong>The sample included: individuals with a lifetime history of non-affective psychosis (n=37), a genetically defined risk group (n=41), a psychometrically defined risk group (n=40), and control group (n=49). All participants carried out an action-recognition task.</p><p><strong>Results: </strong>Number of action-recognition errors was associated with psychosis risk (OR linear trend over 3 levels:1.12, 95% CI1.04-1.20) and differential error rate was associated with the degree of delusional ideation in a dose-response fashion (OR linear trend over 3 levels:1.13, 95% CI1.00-1.26).</p><p><strong>Conclusions: </strong>Alterations in self-monitoring are associated with psychosis with evidence of specificity for delusional ideation. In the risk state, this is expressed more as failure to recognise self-generated actions, whereas in illness failure to recognise alien sources come to the fore.</p>","PeriodicalId":77411,"journal":{"name":"The British journal of psychiatry. Supplement","volume":"51 ","pages":"s58-62"},"PeriodicalIF":0.0,"publicationDate":"2007-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1192/bjp.191.51.s58","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41053137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
S Ruhrmann, A Bechdolf, K-U Kühn, M Wagner, F Schultze-Lutter, B Janssen, K Maurer, H Häfner, W Gaebel, H-J Möller, W Maier, J Klosterkötter
{"title":"Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis.","authors":"S Ruhrmann, A Bechdolf, K-U Kühn, M Wagner, F Schultze-Lutter, B Janssen, K Maurer, H Häfner, W Gaebel, H-J Möller, W Maier, J Klosterkötter","doi":"10.1192/bjp.191.51.s88","DOIUrl":"https://doi.org/10.1192/bjp.191.51.s88","url":null,"abstract":"<p><strong>Background: </strong>People in a putatively late prodromal state not only have an enhanced risk for psychosis but already suffer from mental and functional disturbances.</p><p><strong>Aims: </strong>To evaluate the acute effects of a combined supportive and antipsychotic treatment on prodromal symptoms.</p><p><strong>Method: </strong>Putatively prodromal individuals were randomly assigned to a needs-focused intervention without (n=59) or with amisulpride (n=65). Outcome measures at 12-weeks effects were prodromal symptoms, global functioning and extrapyramidal side-effects.</p><p><strong>Results: </strong>Amisulpride plus the needs-focused intervention produced superior effects on attenuated and full-blown psychotic symptoms, basic, depressive and negative symptoms, and global functioning. Main side-effects were prolactin associated.</p><p><strong>Conclusions: </strong>Coadministration of amisulpride yielded a marked symptomatic benefit. Effects require confirmation by a placebo-controlled study.</p>","PeriodicalId":77411,"journal":{"name":"The British journal of psychiatry. Supplement","volume":"51 ","pages":"s88-95"},"PeriodicalIF":0.0,"publicationDate":"2007-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1192/bjp.191.51.s88","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41053143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Paddy Power, Eduardo Iacoponi, Nicola Reynolds, Helen Fisher, Morris Russell, Philippa Garety, Phillip K McGuire, Tom Craig
{"title":"The Lambeth Early Onset Crisis Assessment Team Study: general practitioner education and access to an early detection team in first-episode psychosis.","authors":"Paddy Power, Eduardo Iacoponi, Nicola Reynolds, Helen Fisher, Morris Russell, Philippa Garety, Phillip K McGuire, Tom Craig","doi":"10.1192/bjp.191.51.s133","DOIUrl":"https://doi.org/10.1192/bjp.191.51.s133","url":null,"abstract":"<p><strong>Background: </strong>There are few evaluations of strategies to improve rates of early detection and treatment of patients with first-episode psychosis.</p><p><strong>Aims: </strong>To evaluate the effectiveness of a general practitioner (GP) education programme and an early detection assessment team (the Lambeth Early Onset Crisis Assessment Team; LEO CAT) in reducing delays in accessing treatment for first-episode psychosis patients.</p><p><strong>Method: </strong>46 clusters of GP practices randomised to GP education in early detection with direct access to LEO CAT v. care as usual. Primary outcome measures were GP referral rates, duration of untreated psychosis (DUP) and delays in receiving treatment.</p><p><strong>Results: </strong>150 patients with first-episode psychosis were recruited; 113 were registered with the study GPs, who referred 54 (47.7%) directly to mental health services. Significantly more intervention group GPs (86.1% v. 65.7%) referred their patients directly to mental health services and fewer patients experienced long delays in receiving treatment. However, their overall DUP was unaffected.</p><p><strong>Conclusions: </strong>Educating GPs improves detection and referral rates of first-episode psychosis patients. An early detection team reduces the long delays in initial assessment and treatment. However, these only impact on the later phases of the DUP. Broader measures, such as public health education, are needed to reduce the earlier delays in DUP.</p>","PeriodicalId":77411,"journal":{"name":"The British journal of psychiatry. Supplement","volume":"51 ","pages":"s133-9"},"PeriodicalIF":0.0,"publicationDate":"2007-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1192/bjp.191.51.s133","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41051512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Prediction of psychosis: setting the stage.","authors":"Alison R Yung, Patrick D McGorry","doi":"10.1192/bjp.191.51.s1","DOIUrl":"https://doi.org/10.1192/bjp.191.51.s1","url":null,"abstract":"<p><p>Treating psychotic disorders in their earliest stages has become a key focus for research and clinical care. This paper reviews evidence of the capacity to identify those at increased risk for psychotic disorder and to intervene in the identified, high-risk individuals to ameliorate the course of disorder. Issues involved in preventive oriented clinical care are addressed, such as risk/benefit considerations, ethical and safety issues and the value of stage-specific interventions. Clinical predictors identified in recent research, promising intervention trials and proposed clinical practice guidelines are described. An approach based on active engagement, support and monitoring, yet with a conservative approach to medication use is advocated at present. Potential neurobiological processes have been studied and reinforce the sense that this is a critical phase for active treatment, and may prove helpful in understanding the process of transition across stages of illness. More research is required in prediction, neurobiology and treatment.</p>","PeriodicalId":77411,"journal":{"name":"The British journal of psychiatry. Supplement","volume":"51 ","pages":"s1-8"},"PeriodicalIF":0.0,"publicationDate":"2007-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1192/bjp.191.51.s1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41052669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kevin D Morgan, Paola Dazzan, Kenneth G Orr, Gerard Hutchinson, Xavier Chitnis, John Suckling, David Lythgoe, Sarah-Jayne Pollock, Susan Rossell, Jane Shapleske, Paul Fearon, Craig Morgan, Anthony David, Philip K McGuire, Peter B Jones, Julian Leff, Robin M Murray
{"title":"Grey matter abnormalities in first-episode schizophrenia and affective psychosis.","authors":"Kevin D Morgan, Paola Dazzan, Kenneth G Orr, Gerard Hutchinson, Xavier Chitnis, John Suckling, David Lythgoe, Sarah-Jayne Pollock, Susan Rossell, Jane Shapleske, Paul Fearon, Craig Morgan, Anthony David, Philip K McGuire, Peter B Jones, Julian Leff, Robin M Murray","doi":"10.1192/bjp.191.51.s111","DOIUrl":"https://doi.org/10.1192/bjp.191.51.s111","url":null,"abstract":"<p><strong>Background: </strong>Grey matter and other structural brain abnormalities are consistently reported in first-onset schizophrenia, but less is known about the extent of neuroanatomical changes in first-onset affective psychosis.</p><p><strong>Aims: </strong>To determine which brain abnormalities are specific to (a) schizophrenia and (b) affective psychosis.</p><p><strong>Method: </strong>We obtained dual-echo (proton density/T2-weighted) magnetic resonance images and carried out voxel-based analysis on the images of 73 patients with first-episode psychosis (schizophrenia n=44, affective psychosis n=29) and 58 healthy controls.</p><p><strong>Results: </strong>Both patients with schizophrenia and patients with affective psychosis had enlarged lateral and third ventricle volumes. Regional cortical grey matter reductions (including bilateral anterior cingulate gyrus, left insula and left fusiform gyrus) were evident in affective psychosis but not in schizophrenia, although patients with schizophrenia displayed decreased hippocampal grey matter and increased striatal grey matter at a more liberal statistical threshold.</p><p><strong>Conclusions: </strong>Both schizophrenia and affective psychosis are associated with volumetric abnormalities at the onset of frank psychosis, with some of these evident in common brain areas.</p>","PeriodicalId":77411,"journal":{"name":"The British journal of psychiatry. Supplement","volume":"51 ","pages":"s111-6"},"PeriodicalIF":0.0,"publicationDate":"2007-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1192/bjp.191.51.s111","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41052672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Julia M Lappin, Paola Dazzan, Kevin Morgan, Craig Morgan, Xavier Chitnis, John Suckling, Paul Fearon, Peter B Jones, Julian Leff, Robin M Murray, Philip K McGuire
{"title":"Duration of prodromal phase and severity of volumetric abnormalities in first-episode psychosis.","authors":"Julia M Lappin, Paola Dazzan, Kevin Morgan, Craig Morgan, Xavier Chitnis, John Suckling, Paul Fearon, Peter B Jones, Julian Leff, Robin M Murray, Philip K McGuire","doi":"10.1192/bjp.191.51.s123","DOIUrl":"https://doi.org/10.1192/bjp.191.51.s123","url":null,"abstract":"<p><strong>Background: </strong>First-episode psychosis is typically preceded by a prodrome in which there is deterioration in global and social functioning.</p><p><strong>Aims: </strong>To examine whether the duration of the prodromal phase influences grey and white matter volumes at the onset of psychosis.</p><p><strong>Methods: </strong>Eighty-two people were scanned using magnetic resonance imaging when they developed a first episode of psychosis. The duration of the prodromal phase was estimated from detailed interviews and medical records. Voxel-based morphometry was used to assess neuroanatomical abnormalities.</p><p><strong>Results: </strong>A long prodromal phase was associated with smaller grey matter volumes in the cingulate, frontal and left insular cortex, and with less white matter volume bilaterally in the superior longitudinal and uncinate fasciculi and the cingulum.</p><p><strong>Conclusions: </strong>The severity of volumetric abnormalities in first-episode psychosis was greater in those with a long prodrome.</p>","PeriodicalId":77411,"journal":{"name":"The British journal of psychiatry. Supplement","volume":"51 ","pages":"s123-7"},"PeriodicalIF":0.0,"publicationDate":"2007-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1192/bjp.191.51.s123","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41052674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Stefan J Borgwardt, Philip K McGuire, Jacqueline Aston, Gregor Berger, Paola Dazzan, Ute Gschwandtner, Marlon Pflüger, Marcus D'Souza, Ernst-Wilhelm Radue, Anita Riecher-Rössler
{"title":"Structural brain abnormalities in individuals with an at-risk mental state who later develop psychosis.","authors":"Stefan J Borgwardt, Philip K McGuire, Jacqueline Aston, Gregor Berger, Paola Dazzan, Ute Gschwandtner, Marlon Pflüger, Marcus D'Souza, Ernst-Wilhelm Radue, Anita Riecher-Rössler","doi":"10.1192/bjp.191.51.s69","DOIUrl":"https://doi.org/10.1192/bjp.191.51.s69","url":null,"abstract":"<p><strong>Background: </strong>Neuroanatomical abnormalities are a well-established feature of schizophrenia. However, the timing of their emergence and the extent to which they are related to vulnerability to the disorder as opposed to psychotic illness itself is unclear.</p><p><strong>Aims: </strong>To assess regional grey matter volume in the at-risk individuals who subsequently developed psychosis.</p><p><strong>Method: </strong>Magnetic resonance imaging data from at-risk individuals who developed psychosis (n=12) within the following 25 months were compared with data from healthy volunteers (n=22) and people with first-episode psychosis (n=25).</p><p><strong>Results: </strong>Compared with healthy volunteers, individuals who subsequently developed psychosis had smaller grey matter volume in the posterior cingulate gyrus, precuneus, and paracentral lobule bilaterally and in the left superior parietal lobule, and greater grey matter volume in a left parietal/posterior temporal region. Compared with first-episode patients, they had relatively greater grey matter volume in the temporal gyrus bilaterally and smaller grey matter volume in the right lentiform nucleus.</p><p><strong>Conclusions: </strong>Some of the structural brain abnormalities in individuals with an at-risk mental state may be related to an increased vulnerability to psychosis, while others are associated with the development of a psychotic illness.</p>","PeriodicalId":77411,"journal":{"name":"The British journal of psychiatry. Supplement","volume":"51 ","pages":"s69-75"},"PeriodicalIF":0.0,"publicationDate":"2007-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1192/bjp.191.51.s69","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41053139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Neuroimaging and other neurobiological indices in schizophrenia: relationship to measurement of functional outcome.","authors":"John L Waddington","doi":"10.1192/bjp.191.50.s52","DOIUrl":"https://doi.org/10.1192/bjp.191.50.s52","url":null,"abstract":"<p><strong>Background: </strong>As understanding of the pathobiology of schizophrenia increases, the challenge is to relate such measures to outcome at a functional level.</p><p><strong>Aims: </strong>To consider our current understanding of how neurobiological variables relate to functional outcome and might constitute outcome measures in their own right.</p><p><strong>Method: </strong>Critical appraisal of recent evidence on structural and functional imaging, neurological evaluation, early neurodevelopmental indices, genomics, proteomics, metabolomics and apoptotic mechanisms in relation to outcome.</p><p><strong>Results: </strong>Studies conducted prospectively from the first episode of schizophrenia are generating more reliable findings but currently lack predictive power. Prediction oftransition from 'highrisk' status to first episode has proved somewhat more fruitful, butthe gain has been modest and circumscribed.</p><p><strong>Conclusions: </strong>Our current level of understanding does not yet allow the generation of predictive models on an individual patient basis. Genomic and metabolomic studies hold particular potential for generating clinically meaningful 'biomarkers' but considerable further work is necessary.</p>","PeriodicalId":77411,"journal":{"name":"The British journal of psychiatry. Supplement","volume":"50 ","pages":"s52-7"},"PeriodicalIF":0.0,"publicationDate":"2007-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1192/bjp.191.50.s52","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27092323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Adverse effects of antipsychotics as outcome measures.","authors":"Samantha Hamer, Peter M Haddad","doi":"10.1192/bjp.191.50.s64","DOIUrl":"https://doi.org/10.1192/bjp.191.50.s64","url":null,"abstract":"<p><strong>Background: </strong>Antipsychotic drugs are associated with adverse effects that can lead to poor medication adherence, stigma, distress and impaired quality of life.</p><p><strong>Aims: </strong>To review the use of adverse effects of antipsychotic drugs as outcome measures, with a particular emphasis on methodological issues.</p><p><strong>Method: </strong>Review of data on adverse effects from sources including randomised controlled trials (RCTs), post-marketing surveillance and naturalistic studies.</p><p><strong>Results: </strong>All have advantages and disadvantages and the best overview comes from considering all sources of data together. Adverse effects are inconsistently reported, hampering cross-study comparisons. Many outcome measures lack clinical meaning. In both naturalistic studies and RCTs adverse effects often account for less treatment discontinuation than lack of efficacy.</p><p><strong>Conclusions: </strong>Standardisation in the reporting of adverse effects is needed. Patients' subjective experience of medication should be given more consideration. Total discontinuation rates provide a useful global outcome measure that incorporates tolerability and efficacy as well as patient and clinician viewpoints. Patients should be informed of common side-effects prior to treatment and monitored for their occurrence during treatment.</p>","PeriodicalId":77411,"journal":{"name":"The British journal of psychiatry. Supplement","volume":"50 ","pages":"s64-70"},"PeriodicalIF":0.0,"publicationDate":"2007-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1192/bjp.191.50.s64","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27092325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}